About this trial
The communication of an altered Pap smear or positive HPV test has a strong impact on patients on a psychological level. HPV positive women are more likely to have higher level of stress, anxiety, depression and impaired sexual life.
The examiner want to establish this impact through different surveys (DASS-21 (Depression Anxiety Stress Scales); PCL-5 (Posttraumatic Stress Disorder Checklist); DTS (Dyadic Trust Scale), CDDQ (Cervical Dysplasia Distress Questionnaire) and MPI (Match Patient Inventory) from the moment the patient receives the news until after completing treatment for her intraepithelial neoplasia.
Eligibility criteria
Qualifiers
patients accessing our Colposcopy service from Prevenzione Serena program with an altered pap smear or a two-times positive HPV test
patients with biopsy result of HSIL
ability to fill in surveys via e-mail
Disqualifiers
previous access in our Colposcopy service
patients not enrolled in Prevenzione Serena
pregnant patients
inability to fill in surveys via email
Trial design
Treatments tested in this trial
- Not listed